Glycogen phosphorylation and Lafora disease.

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Covalent phosphorylation of glycogen was first described decades ago.
• Recent research has focused on glycogen phosphorylation due to its link with Lafora disease, a fatal epilepsy caused by mutations in the glycogen-binding phosphatase laforin.
• Glycogen phosphorylation involves phosphomonoesters at C2, C3, and C6 positions of glucose residues, occurring at a low frequency.

Purpose of the Study:

• To investigate the mechanisms of glycogen phosphorylation.
• To understand the role of glycogen phosphorylation in the pathogenesis of Lafora disease.
• To explore the structural and functional abnormalities of glycogen associated with Lafora disease.

Main Methods:

• Analysis of glycogen structure and phosphorylation levels.
• Investigation of potential enzymatic pathways involved in glycogen phosphorylation.
• Correlation of glycogen abnormalities with Lafora disease phenotypes.

Main Results:

• Glycogen phosphorylation, though rare, is implicated in Lafora disease.
• Abnormal glycogen in Lafora disease exhibits elevated phosphorylation, reduced branching, and insolubility.
• Lafora bodies, insoluble glycogen deposits in neurons, are a hallmark of the disease.

Conclusions:

• Hyperphosphorylation of glycogen is a key feature of Lafora disease.
• Abnormal glycogen accumulation and aggregation contribute to neuronal dysfunction and epilepsy.
• Further research into glycogen phosphorylation mechanisms is crucial for understanding and treating Lafora disease.